• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：一项关于雾化吸入α1b干扰素治疗婴幼儿毛细支气管炎的多中心随机前瞻性研究。

Correction: A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization.

作者信息

Chen Lina, Shi Mingfang, Deng Quanmin, Liu Wenjun, Li Qin, Ye Piao, Yu Xiahui, Zhang Benjin, Xu Yuxia, Li Xiaolan, Yang Yao, Li Min, Yan Yi, Xu Zhe, Yu Jing, Xiang Long, Tang Xiaojun, Wan Guangping, Cai Qiang, Wang Li, Hu Bo, Xie Liang, Li Gen, Xie Lunyan, Liu Xiaoyun, Liu Chunyan, Li Li, Chen Lijie, Jiang Xiaobin, Huang Yana, Wang Si, Guo Jiang, Shi Yan, Li Li, Wang Xiaofang, Zhao Zhiyong, Li Yan, Liu Yanru, Fu Qiang, Zeng Yan, Zou Yan, Liu Dingyuan, Wan Deyun, Ai Tao, Liu Hanmin

出版信息

PLoS One. 2020 Apr 10;15(4):e0231911. doi: 10.1371/journal.pone.0231911. eCollection 2020.

DOI:10.1371/journal.pone.0231911
PMID:32275690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7147733/
Abstract

[This corrects the article DOI: 10.1371/journal.pone.0228391.].

摘要

[本文更正了文章的数字对象标识符：10.1371/journal.pone.0228391。]

相似文献

1
Correction: A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization.更正：一项关于雾化吸入α1b干扰素治疗婴幼儿毛细支气管炎的多中心随机前瞻性研究。
PLoS One. 2020 Apr 10;15(4):e0231911. doi: 10.1371/journal.pone.0231911. eCollection 2020.
2
A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization.干扰素α1b 雾化治疗毛细支气管炎的多中心随机前瞻性研究。
PLoS One. 2020 Feb 21;15(2):e0228391. doi: 10.1371/journal.pone.0228391. eCollection 2020.
3
Correction: Safely Discharging Infants with Bronchiolitis from an Emergency Department: A Five Step Guide for Pediatricians.更正：从急诊科安全出院患细支气管炎的婴儿：儿科医生五步指南。
PLoS One. 2016 Nov 2;11(11):e0166256. doi: 10.1371/journal.pone.0166256. eCollection 2016.
4
Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.更正：一项随机、开放标签、平行、多中心IV期研究，旨在比较阿托伐他汀10毫克和20毫克在高危亚洲高胆固醇血症患者中的疗效和安全性。
PLoS One. 2021 Oct 20;16(10):e0259072. doi: 10.1371/journal.pone.0259072. eCollection 2021.
5
Correction: The learning curve of endoscopic total mastectomy in Taiwan: A multi-center study.更正：台湾地区内镜下全乳切除术的学习曲线：一项多中心研究。
PLoS One. 2017 Aug 17;12(8):e0183638. doi: 10.1371/journal.pone.0183638. eCollection 2017.
6
Correction: Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?- A Prospective Randomized Controlled Trial.更正：内脏整骨疗法能否加速极低出生体重儿的胎粪排出？——一项前瞻性随机对照试验。
PLoS One. 2017 Nov 2;12(11):e0187784. doi: 10.1371/journal.pone.0187784. eCollection 2017.
7
Correction: Heart rate recovery and morbidity after noncardiac surgery: Planned secondary analysis of two prospective, multi-centre, blinded observational studies.更正：非心脏手术后的心率恢复与发病率：两项前瞻性、多中心、盲法观察性研究的计划二次分析
PLoS One. 2019 Dec 5;14(12):e0226379. doi: 10.1371/journal.pone.0226379. eCollection 2019.
8
Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.更正：那他珠单抗可稳定疾病活动的身体、认知、MRI和OCT标志物：一项前瞻性、非随机的试点研究。
PLoS One. 2017 May 18;12(5):e0178338. doi: 10.1371/journal.pone.0178338. eCollection 2017.
9
Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.更正：血清25-羟基维生素D浓度≥40 ng/ml与癌症风险降低>65%相关：随机试验和前瞻性队列研究的汇总分析。
PLoS One. 2018 Jul 16;13(7):e0201078. doi: 10.1371/journal.pone.0201078. eCollection 2018.
10
Correction: Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.更正：干扰素（I型和III型）治疗COVID-19患者的临床疗效和安全性：一项随机对照试验的系统评价和荟萃分析。
PLoS One. 2023 Dec 15;18(12):e0296219. doi: 10.1371/journal.pone.0296219. eCollection 2023.

引用本文的文献

1
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers.雾化吸入GB05-人干扰素α1b溶液的安全性、耐受性及药代动力学：一项针对健康中国成年志愿者的随机、安慰剂对照、剂量递增的I期研究
Infect Dis Ther. 2024 Sep;13(9):2053-2070. doi: 10.1007/s40121-024-01024-y. Epub 2024 Aug 4.
2
Pharmaco-Immunomodulatory Therapy in COVID-19.COVID-19 的药物免疫调节治疗。
Drugs. 2020 Sep;80(13):1267-1292. doi: 10.1007/s40265-020-01367-z.

本文引用的文献

1
A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization.干扰素α1b 雾化治疗毛细支气管炎的多中心随机前瞻性研究。
PLoS One. 2020 Feb 21;15(2):e0228391. doi: 10.1371/journal.pone.0228391. eCollection 2020.